Approval · Notice of Compliance 14022 · 2013
CUROSURF: Notice of Compliance 14022
Issued January 16, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14022
- Date
- January 16, 2013
- Company
- Chiesi Farmaceutici S P A
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Chemistry and manufacturing information update
- Therapeutic class
- Lung surfactant
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CUROSURF | Not yet assigned | — |
Medicinal ingredients
- PORACTANT ALFA 80 MG per ML